Monday, May 17, 2021

Re: [IAC#RG] Some good news on vaccine front

"Bikash Bhattacharya" (via indiaresists Mailing List)
<indiaresists-3hfIC0tI0F+k/GrYEfjPQg@public.gmane.org> writes:

> FYI, These *COVISHIELD vaccines were rejected in USA*
> <https://www.fiercepharma.com/pharma/fda-could-reject-astra-zeneca-s-covid-vaccine-efficacy-and-manufacturing-shortfalls-analyst>
> because they don't work too well on the new more aggressive variants
> ...

This is opposite of what I have read till now about mRNA vaccines. I
have read that the mRNA vaccine is not effective for new variants and
they will release a new booster dose for each new variant or a set of
variants.

Could you please clarify, Mr. Bikash, if my understanding is wrong?

--
Regards,
Pankaj Jangid

[IAC#RG] Chaos is necessary to the birth of a news star

Comrades,

The HRA manifesto began with Nietzche's phrase Chaos is necessary to the birth of a new star, which was also incorporated into IAC's 2013 manifesto, with the approval of all those present here today, in the section for surgical strikes against Hindustan's enemies,

In the past 7 years the times for homeopathic remedies have come and gone, as has also those for allopathic remedies described in our manifesto.

We believe the time is now ripe for 'surgical strikes' so that HRA's revolutionary new star HINDUSTAN can shine brightly on the global firmament after her enemy's bones have been ground to dust and their flesh fed to the carrion crows.

Accordingly, IAC members must start preparing the lists of HRA's enemies so that corruption can be surgically eliminated without mercy wherever or whenever they are found.

Ajay Dixit
Founding member IAC
Switzerland

Re: [IAC#RG] Some good news on vaccine front

Dear Friend

There is nothing wrong with these COVISHIELD vaccines which would otherwise go stale in the USA in 2 or 3 months.

FYI, These COVISHIELD vaccines were rejected in USA because they don't work too well on the new more aggressive variants and also their efficiency is around 50% per dose as compared to 90% plus of USA mRNA vaccines like Pfizers and Moderna. So whereas in a 2 dose combination the COVISHILED can theoretically achieve 75% safety the USA vaccines will achieve 99.3% safety. However the USA vaccines are 5 times the cost of COVISHIELD so it is a simple management decision for poor country like India to go for COVISHIELD option considering the precarious economy (we are about to be declared as JUNK bond) by rating agencies) and the vast population to be innoculated so they can eke out their living  in absence of state support and social security.

In simple language, "Beggars cannot be choosers".

Bikash Bhattacharya
Member Covid Task Force
Laghu Udyog Bharti (WB)

On Mon, May 17, 2021 at 5:55 PM ヴィカス ヤダヴァ (vikas yadav) <indiaresists@lists.riseup.net> wrote:
Anyone knows why "rejected for use in the USA"?

On Mon, 17 May 2021, 15:47 Sandeep Nagpal, <indiaresists@lists.riseup.net> wrote:
A very good strategy to make (secret) profits... export price of USD 3.75 and reimport price of USD 11.83...

On Mon, May 17, 2021 at 4:51 AM Bikash Bhattacharya <indiaresists@lists.riseup.net> wrote:
Friends

Finally, a good news on the vaccine front.

The USA has agreed to sell 38 million vials out of the 62 million vials unused AstraZeneca (ie. COVISHIELD equivalent) vaccines to India which were rejected for use in the USA and are lying there since past 2 months. All these 38 million vials were manufactured in India and contain enough vaccine for 10 doses per vial so about 170 million persons can be vaccinated in the next 2 weeks after the vials begin arriving. It will be especially useful for vaccination by corporations and industries as the nation needs to keep the economy going at all costs.

The prices for each COVISHIELD dose will be US$ 11.83 (i.e. estimated approx Rs. 800 per shot in a State govt hospital and Rs.1,800 in a private hospital for 1 dose). These vials were exported at equivalent US$ 3.75 for each 0.5 ml dose from India by Serum India, Pune.

This is a wonderful achievement brought about by Hon'ble Prime Minister's direct talks with USA President Joseph Biden, as otherwise all the State govt global tenders under revised vaccine policy were being L1'd by Chinese vaccine manufacturers like Sinopharm which are the low efficiency vaccines.

Bikash Bhattacharya
Member Covid Task Force
Laghu Udyog Bharti (WB)

Re: [IAC#RG] Some good news on vaccine front

Anyone knows why "rejected for use in the USA"?

On Mon, 17 May 2021, 15:47 Sandeep Nagpal, <indiaresists@lists.riseup.net> wrote:
A very good strategy to make (secret) profits... export price of USD 3.75 and reimport price of USD 11.83...

On Mon, May 17, 2021 at 4:51 AM Bikash Bhattacharya <indiaresists@lists.riseup.net> wrote:
Friends

Finally, a good news on the vaccine front.

The USA has agreed to sell 38 million vials out of the 62 million vials unused AstraZeneca (ie. COVISHIELD equivalent) vaccines to India which were rejected for use in the USA and are lying there since past 2 months. All these 38 million vials were manufactured in India and contain enough vaccine for 10 doses per vial so about 170 million persons can be vaccinated in the next 2 weeks after the vials begin arriving. It will be especially useful for vaccination by corporations and industries as the nation needs to keep the economy going at all costs.

The prices for each COVISHIELD dose will be US$ 11.83 (i.e. estimated approx Rs. 800 per shot in a State govt hospital and Rs.1,800 in a private hospital for 1 dose). These vials were exported at equivalent US$ 3.75 for each 0.5 ml dose from India by Serum India, Pune.

This is a wonderful achievement brought about by Hon'ble Prime Minister's direct talks with USA President Joseph Biden, as otherwise all the State govt global tenders under revised vaccine policy were being L1'd by Chinese vaccine manufacturers like Sinopharm which are the low efficiency vaccines.

Bikash Bhattacharya
Member Covid Task Force
Laghu Udyog Bharti (WB)
Post: "indiaresists@lists.riseup.net"
Exit: "indiaresists-unsubscribe@lists.riseup.net"
Quit: "https://lists.riseup.net/www/signoff/indiaresists"
Help: https://help.riseup.net/en/list-user
WWW : http://indiaagainstcorruption.net.in
Post: "indiaresists@lists.riseup.net"
Exit: "indiaresists-unsubscribe@lists.riseup.net"
Quit: "https://lists.riseup.net/www/signoff/indiaresists"
Help: https://help.riseup.net/en/list-user
WWW : http://indiaagainstcorruption.net.in

Re: [IAC#RG] New DRDO Drug 2-DG is based on Acharya Balkrishna’s research

So this drug has been in experimentation for very long in INMAS-DRDO. Even many years before COVID came into existence, DRDO was using it as an radioprotective drug against tumor cells. 

Check the author list, after Acharya Balkrishna, another name is Dr. Pallavi Thakur, who is an ex-INMAS fellow. Also, you may find the research articles published by INMAS in the given link.

https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=2+deoxy+d+glucose+INMAS&btnG=.  Patanjali has done some simulation work on the effectiveness of 2-Deoxy D Glucose, but not actual clinical trials. 

 


Kanishka Sharma, Ph.D.



From: indiaresists-request@lists.riseup.net <indiaresists-request@lists.riseup.net> on behalf of Pankaj Jangid <pankaj@codeisgreat.org>
Sent: Friday, May 14, 2021 10:25 AM
To: indiaresists@lists.riseup.net <indiaresists@lists.riseup.net>
Subject: [IAC#RG] New DRDO Drug 2-DG is based on Acharya Balkrishna's research
 
I started to dig about this new drug 2-DG, which was launched last week
by DRDO and Dr. Reddy's. This drug is claimed to reduce the oxygen
demand by a body infected with covid-19.

Reading more on this, I found that this is actually based on a research
paper by Acharya Balkrishna et al. of Patanjali Ayurveda. Here is the
original paper published on the aggregator ResearchGate:

https://www.researchgate.net/publication/340332773_Glucose_antimetabolite_2-Deoxy-D-Glucose_and_its_derivative_as_promising_candidates_for_tackling_COVID-19_Insights_derived_from_in_silico_docking_and_molecular_simulations

--
Regards,
Pankaj Jangid

Sunday, May 16, 2021

Re: [IAC#RG] Some good news on vaccine front

A very good strategy to make (secret) profits... export price of USD 3.75 and reimport price of USD 11.83...

On Mon, May 17, 2021 at 4:51 AM Bikash Bhattacharya <indiaresists@lists.riseup.net> wrote:
Friends

Finally, a good news on the vaccine front.

The USA has agreed to sell 38 million vials out of the 62 million vials unused AstraZeneca (ie. COVISHIELD equivalent) vaccines to India which were rejected for use in the USA and are lying there since past 2 months. All these 38 million vials were manufactured in India and contain enough vaccine for 10 doses per vial so about 170 million persons can be vaccinated in the next 2 weeks after the vials begin arriving. It will be especially useful for vaccination by corporations and industries as the nation needs to keep the economy going at all costs.

The prices for each COVISHIELD dose will be US$ 11.83 (i.e. estimated approx Rs. 800 per shot in a State govt hospital and Rs.1,800 in a private hospital for 1 dose). These vials were exported at equivalent US$ 3.75 for each 0.5 ml dose from India by Serum India, Pune.

This is a wonderful achievement brought about by Hon'ble Prime Minister's direct talks with USA President Joseph Biden, as otherwise all the State govt global tenders under revised vaccine policy were being L1'd by Chinese vaccine manufacturers like Sinopharm which are the low efficiency vaccines.

Bikash Bhattacharya
Member Covid Task Force
Laghu Udyog Bharti (WB)
Post: "indiaresists@lists.riseup.net"
Exit: "indiaresists-unsubscribe@lists.riseup.net"
Quit: "https://lists.riseup.net/www/signoff/indiaresists"
Help: https://help.riseup.net/en/list-user
WWW : http://indiaagainstcorruption.net.in

Re: [IAC#RG] Another fake COVID-19 drug gets approval from CORRUPT DCGI

Dear Ms. Kotwal and  Dr. Rajan

Although the 2-DG molecules have been used extensively for cancer treatment it still lacks approval from the regulators as an anti-cancer drug for the reason that the 2-DG's theory of glycolysis inhibition destroying malignant cells is still unproven on humans.

It is well known by now, the the DRDO is a completely useless body packed with the most stupid and otherwise unemployable scientists ever assembled in one organsiation. No private company worth the name would hire these DRDO morons, Patanjali being the notable exception so as to tomtom that Baba-no-Swami-no-Rishi Ramdev (or his homosexual buddy) invented 2-DG.

Dr. Rajan does a great disservice to our members by not linking to the Hindu article he referred to which exposed 2-DG is a FAKE DRUG,

There is also no doubt that 2-DG is a FAKE DRUG for COVID treatment, and it's as fake as that Nepali billionaire "inter"-fail rogue "Acharya" Balkrishna's medical / research qualifications are.

From these kinds of dubious approvals, it is also undeniable that present DCGI  Dr. V.G Somani (probably a Gujarati like the rest of Modi's key appointees) is a corrupt and pliable rubber stamp Drugs regulator, handpicked by Modi to carry out the final scams of a Govt on its way out.

NB: Anyone promoting fake COVID drugs / cures / quacks on this mailing list will be unsubscribed without notice.

RS Dalvi
List Administrator
Camp: Germany (Europe)

On Sat, May 15, 2021 at 11:20 PM Swati Kotwal <indiaresists@lists.riseup.net> wrote:
Dear all, 
Thanks to Dr Rajan for his reply. There is lot of research on 2-DG use in cancer treatment. Considering the fact that there is no proven and 100% effective drug against COVID, research community is testing the efficacy of various antiviral n other drugs to treat COVID (repurposed drug). Kudos to DRDO and let us hope that the drug is successful. 

Dr Swati Kotwal (Retd)
University Department of Biochemistry RTMNU Nagpur

Sent from my iPhone

On 14-May-2021, at 8:17 PM, m.g.r. rajan <mgr_rajan@hotmail.com> wrote:

I too searched literature on 2-DG and found this pre-print (meaning not peer-reviewed) publication from Patanjali on Researchgate website. It is a theoretical study based on computer simulation. One of the co-authors is an ex-Director of a DRDO-Institute. 

2-DG is a long-known molecule, having been developed as an anti-cancer metabolite. The present group has boldly tested it in Covid-19 patients and have shown favourable results and have obtained DCGI-approval. To that extent the work done is novel. It remains to be seen how it works out in field use. The side effects 

Incidentally, DRDO-INMAS has published papers using this molecule more than a decade ago as an adjuvant in radiation therapy for a few cancers. 

However, some experts have expressed reservations against 2-DG for treating covid-19 patients as expressed in The Hindu. 

There is a Swedish company that announced on March 11th, a nasal spray containing 2-DG.

Dr. Rajan

From: indiaresists-request@lists.riseup.net <indiaresists-request@lists.riseup.net> on behalf of Pankaj Jangid <pankaj@codeisgreat.org>
Sent: Friday, May 14, 2021 10:25 AM
To: indiaresists@lists.riseup.net <indiaresists@lists.riseup.net>
Subject: [IAC#RG] New DRDO Drug 2-DG is based on Acharya Balkrishna's research
 
I started to dig about this new drug 2-DG, which was launched last week
by DRDO and Dr. Reddy's. This drug is claimed to reduce the oxygen
demand by a body infected with covid-19.

Reading more on this, I found that this is actually based on a research
paper by Acharya Balkrishna et al. of Patanjali Ayurveda. Here is the
original paper published on the aggregator ResearchGate:

https://na01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.researchgate.net%2Fpublication%2F340332773_Glucose_antimetabolite_2-Deoxy-D-Glucose_and_its_derivative_as_promising_candidates_for_tackling_COVID-19_Insights_derived_from_in_silico_docking_and_molecular_simulations&amp;data=04%7C01%7C%7Caac01eb4e3cf44a4a7fc08d916bb719d%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637565816615923917%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=a8ahOYlOxOBv6QoAL4ICihR09l%2Fa2tDD%2FMf82uU95SE%3D&amp;reserved=0

--
Regards,
Pankaj Jangid
Post: "indiaresists@lists.riseup.net"
Exit: "indiaresists-unsubscribe@lists.riseup.net"
Quit: "https://lists.riseup.net/www/signoff/indiaresists"
Help: https://help.riseup.net/en/list-user
WWW : http://indiaagainstcorruption.net.in
Post: "indiaresists@lists.riseup.net"
Exit: "indiaresists-unsubscribe@lists.riseup.net"
Quit: "https://lists.riseup.net/www/signoff/indiaresists"
Help: https://help.riseup.net/en/list-user
WWW : http://indiaagainstcorruption.net.in